Effects of chelators (desferal, deferiprone & deferaairox) on the growth of klebsiella and aeromonas isolated from transfusion dependent thalassemia patients [PDF]
, 2010 Poster Presentation (Doctor’s Session)Infection is among the leading causes of death for thalassemia major patients. The known predisposing factors of infection include prior splenectomy, iron overload and use of iron chelator such as desferal ...
Chan, GCF, Chan, S, Ha, SY, Ho, PL
core
Iron Chelator Drugs in Transfusion Dependent Thalassemia: a Review
Armaghane Danesh Bimonthly Journal, 2020 Background & aim: Thalassemia syndromes are the most common inherited hemoglobinopathies in the world characterized by various degrees of defective production of the alpha or beta globin chains.
M Hashemieh
doaj
Caspian Journal of Internal Medicine, 2017 Background: Cardiac complications due to iron overload are the most common cause of death in patients with thalassemia major. The aim of this study was to compare iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and ...
Shahla Ansari +4 more
doaj
Safety of deferasirox as an oral iron chelator in thalassemic children
, 2016 Shikha Jaiswal +4 more
openalex +2 more sources
Approaching low liver iron burden in chelated patients with non‐transfusion‐dependent thalassemia: the safety profile of deferasirox [PDF]
, 2014 Alì Taher +11 more
openalex +1 more source
Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo [PDF]
, 2016 core +1 more source
Oral iron chelation therapy with deferiprone in patients with Thalassemia Major [PDF]
, 2009 OBJECTIVE: To determine the efficacy and adverse effects of deferiprone in patients with Thalassemia Major. METHODS: A prospective case series study was conducted at the Fatimid Foundation Blood Bank and Haematological Diseases center Lahore.
Adil, Salman +3 more
core +1 more source
MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox [PDF]
, 2015 Alessia Pepe +9 more
core +1 more source
Lactose intolerance is not the cause of gastrointestinal adverse effects in beta thalassemia patients treated with deferasirox [PDF]
, 2014 Idit Pazgal +5 more
openalex +1 more source